This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Nexttobe Ab. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Olof Kämpe: Innovator in Recombinant Protein Technology
Introduction
Olof Kämpe is a notable inventor based in Uppsala, Sweden. He has made significant contributions to the field of biotechnology, particularly in the development of recombinant proteins. His work focuses on addressing medical conditions such as phenylketonuria, a metabolic disorder that requires innovative solutions.
Latest Patents
Olof Kämpe holds 1 patent for his invention titled "Recombinant Phe-free proteins for use in the treatment of phenylketonuria." This patent describes a method for preparing recombinant Phe-free or Phe-low proteins. The method involves using an expression system and/or a recombinant host cell that incorporates a nucleotide encoding the desired protein into its genome.
Career Highlights
Throughout his career, Olof Kämpe has worked with various companies, including Nexttobe AB and Tanea Medical AB. His experience in these organizations has allowed him to apply his innovative ideas in practical settings, contributing to advancements in medical treatments.
Collaborations
Olof Kämpe has collaborated with Qingshan Li, further enhancing his research and development efforts in the field of recombinant proteins.
Conclusion
Olof Kämpe's work in recombinant protein technology exemplifies the impact of innovation in addressing complex medical challenges. His contributions continue to influence the biotechnology landscape, paving the way for future advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile